Morgan Stanley’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.3M | Sell |
791,222
-659,412
| -45% | -$31.3M | ﹤0.01% | 2555 |
|
|
2026
Q1 | $74.8M | Buy |
1,450,634
+190,872
| +15% | +$13.4M | ﹤0.01% | 1700 |
|
|
2025
Q4 | $116M | Buy |
1,259,762
+809,121
| +180% | +$77.4M | 0.01% | 1318 |
|
|
2025
Q3 | $33.4M | Buy |
450,641
+147,769
| +49% | +$15M | ﹤0.01% | 2385 |
|
|
2025
Q2 | $39.3M | Sell |
302,872
-136,246
| -31% | -$19.8M | ﹤0.01% | 2142 |
|
|
2025
Q1 | $69.9M | Sell |
439,118
-145,510
| -25% | -$26.3M | 0.01% | 1515 |
|
|
2024
Q4 | $108M | Buy |
584,628
+221,321
| +61% | +$43M | 0.01% | 1192 |
|
|
2024
Q3 | $76.7M | Buy |
363,307
+105,931
| +41% | +$18.4M | 0.01% | 1446 |
|
|
2024
Q2 | $34.4M | Buy |
257,376
+120,805
| +88% | +$22.9M | ﹤0.01% | 2110 |
|
|
2024
Q1 | $29.3M | Sell |
136,571
-36,992
| -21% | -$7.25M | ﹤0.01% | 2271 |
|
|
2023
Q4 | $35.3M | Buy |
173,563
+48,816
| +39% | +$7.91M | ﹤0.01% | 2079 |
|
|
2023
Q3 | $24.8M | Sell |
124,747
-65,661
| -34% | -$16.6M | ﹤0.01% | 2232 |
|
|
2023
Q2 | $61.8M | Buy |
190,408
+8,991
| +5% | +$2.57M | 0.01% | 1408 |
|
|
2023
Q1 | $42.5M | Buy |
181,417
+50,627
| +39% | +$12.8M | ﹤0.01% | 1696 |
|
|
2022
Q4 | $32.9M | Buy |
130,790
+13,727
| +12% | +$2.93M | ﹤0.01% | 1874 |
|
|
2022
Q3 | $20.8M | Sell |
117,063
-32,817
| -22% | -$6.59M | ﹤0.01% | 2149 |
|
|
2022
Q2 | $27.4M | Buy |
149,880
+22,625
| +18% | +$4.51M | ﹤0.01% | 1941 |
|
|
2022
Q1 | $32.7M | Sell |
127,255
-34,990
| -22% | -$8M | ﹤0.01% | 1631 |
|
|
2021
Q4 | $37.3M | Sell |
162,245
-107,604
| -40% | -$26.3M | ﹤0.01% | 1563 |
|
|
2021
Q3 | $62.8M | Sell |
269,849
-53,953
| -17% | -$11.3M | 0.01% | 1142 |
|
|
2021
Q2 | $62.6M | Buy |
323,802
+30,570
| +10% | +$6.06M | 0.01% | 1153 |
|
|
2021
Q1 | $60.7M | Buy |
293,232
+42,232
| +17% | +$8.97M | 0.01% | 1043 |
|
|
2020
Q4 | $47.2M | Buy |
251,000
+7,397
| +3% | +$1.21M | 0.01% | 1139 |
|
|
2020
Q3 | $31.4M | Sell |
243,603
-160,769
| -40% | -$17.7M | 0.01% | 1163 |
|
|
2020
Q2 | $35.2M | Sell |
404,372
-3,842
| -0.9% | -$295K | 0.01% | 1047 |
|
|
2020
Q1 | $24.6M | Sell |
408,214
-1,300,297
| -76% | -$96.2M | 0.01% | 1134 |
|
|
2019
Q4 | $127M | Sell |
1,708,511
-321,413
| -16% | -$20.7M | 0.03% | 516 |
|
|
2019
Q3 | $124M | Buy |
2,029,924
+588,844
| +41% | +$38.8M | 0.03% | 484 |
|
|
2019
Q2 | $87.4M | Buy |
1,441,080
+50,166
| +4% | +$2.7M | 0.02% | 595 |
|
|
2019
Q1 | $79M | Buy |
1,390,914
+907,003
| +187% | +$49M | 0.02% | 625 |
|
|
2018
Q4 | $20.4M | Buy |
483,911
+469,496
| +3,257% | +$20M | 0.01% | 1437 |
|
|
2018
Q3 | $607K | Sell |
14,415
-3,927
| -21% | -$184K | ﹤0.01% | 4886 |
|
|
2018
Q2 | $654K | Buy |
+18,342
| New | +$592K | ﹤0.01% | 4915 |
|
Other funds holding INSP
SCM
DM
Morgan Stanley's INSP Position: Q2 2026 in Review
Morgan Stanley reduced its Inspire Medical Systems (INSP) stake by 45% in Q2 2026, selling an estimated $31.3M and leaving 791,222 shares worth $35.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2555.
Morgan Stanley first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $127M in Q4 2019. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- Morgan Stanley held 791,222 shares of Inspire Medical Systems worth $35.3M as of Q2 2026.
- Morgan Stanley sold 659,412 Inspire Medical Systems shares in Q2 2026, an estimated $31.3M.
- Inspire Medical Systems made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2555 holding.
- Morgan Stanley first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
- Morgan Stanley's Inspire Medical Systems position peaked at $127M in Q4 2019.
- 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.